Challenges of implementing a large scale larviciding campaign against malaria in rural Burkina Faso - lessons learned and recommendations derived from the EMIRA project.
BACKGROUND
Recent malaria control and elimination attempts show remarkable success in several parts of sub-Saharan Africa. Vector control via larval source management represents a new and to date underrepresented approach in low income countries to further reduce malaria transmission. Although the positive impact of such campaigns on malaria incidence has been researched, there is a lack of data on which prerequisites are needed for implementing such programs on a routine basis on large scale. Our objectives are to point out important steps in implementing an anti-malaria larviciding campaign in a resource and infrastructure restraint setting and share the lessons learned from our experience during a three-year intervention study in rural Burkina Faso.


METHODS
We describe the approaches we followed and the challenges that have been encountered during the EMIRA project, a three-year study on the impact of environmental larviciding on vector ecology and human health. An inventory of all performed work packages and associated problems and peculiarities was assembled.


RESULTS
Key to the successful implementation of the larviciding program within a health district was the support and infrastructure from the local research center run by the government. This included availability of trained scientific personnel for local project management, data collection and analysis by medical personnel, entomologists and demographers and teams of fieldworkers for the larviciding intervention. A detailed a priori assessment of the environment and vector breeding site ecology was essential to calculate personnel requirements and the need for larvicide and application apparel. In our case of a three-year project, solid funding for the whole duration was an important issue, which restricted the number of possible donors. We found the acquisition of qualified field personnel in fair numbers not to be always easy and training in application techniques and basic entomologic knowledge required several weeks of theoretical and practical formation. A further crucial point was to establish an effective quality control system that ensured the timely verification of larviciding success and facilitated in time data handling. While the experiences of running a larviciding campaign may vary globally, the experiences gained and the methods used in the Nouna health district may be employed in similar settings.


CONCLUSIONS
Our observations highlight important components and strategies that should be taken into account when planning and running a similar larviciding program against malaria in a resource limited setting. A strong local partnership, meticulous planning with the possibility of ad-hoc adaption of project components and a reliable source of funding turned out to be crucial factors to successfully accomplish such a project.
Institute of Public Health, University of Heidelberg, Heidelberg, Germany. peter.dambach@web.de.
Peter
P
Dambach
Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.
Issouf
I
Traoré
German Mosquito Control Association (KABS), Speyer, Germany.
Achim
A
Kaiser
Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.
Ali
A
Sié
Institute of Public Health, University of Heidelberg, Heidelberg, Germany.
Rainer
R
Sauerborn
German Mosquito Control Association (KABS), Speyer, Germany.|Centre for Organismal Studies, University of Heidelberg, Heidelberg, Germany.
Norbert
N
Becker
Bacillus thuringiensis israelensis; Burkina Faso; Larviciding; Malaria; Vector control
Parasitol Res. 2011 Jun;108(6):1355-63
20730445
Glob Health Action. 2014 Nov 05;7:25908
25377345
Lancet. 2010 Nov 6;376(9752):1592-603
21035841
Bull World Health Organ. 2009 Sep;87(9):655-65
19784445
Malar J. 2014 Dec 04;13:477
25476586
Trends Parasitol. 2008 Oct;24(10):449-54
18760671
Int J Epidemiol. 2012 Jun;41(3):579-88
22798690
Parasitol Today. 1997 Dec;13(12):485-7
15275138
Indian J Med Res. 1997 Aug;106:174-97
9291686
Malar J. 2006 Apr 24;5:33
16635265
Cochrane Database Syst Rev. 2013 Aug 29;(8):CD008923
23986463
Am J Trop Med Hyg. 2010 Feb;82(2):176-84
20133989
S Afr Med J. 2014 Mar;104(3 Suppl 1):224-7
24893497
Lancet. 2010 Nov 6;376(9752):1604-15
21035839
Malar J. 2007 Jun 07;6:76
17555570
Trop Med Int Health. 2006 Nov;11(11):1629-42
17054742